Paper Details

  1. Home
  2. Paper Details

New and experimental skin-directed therapies for cutaneous lymphomas.

Author: DummerReinhard, FarkasArpad, FrenchLars E, KemenyLajos

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Overview

Primary cutaneous lymphomas are rare diseases with no definitive cure. Local therapies, including topical agents and new developments such as gene therapy and photodynamic therapy, are used to control the disease and alleviate symptoms.
Paper Details　
Original Abstract of the Article :
Primary cutaneous lymphomas (CLs) originate in the skin and should be differentiated from secondary skin infiltrates, which are manifestations of lymphomas of nodal or extranodal origin. These rare diseases include various lymphoproliferative disorders: cutaneous T-cell lymphomas, cutaneous B-cell l...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000241302

データ提供：米国国立医学図書館（NLM）

New Frontiers in Cutaneous Lymphoma Treatment: Skin-Directed Therapies

Cutaneous lymphomas are a group of rare cancers that affect the skin. This review explores the latest developments in skin-directed therapies for primary cutaneous lymphomas (CLs). The review highlights the importance of differentiating between primary CLs and secondary skin infiltrates, which are manifestations of lymphomas of nodal or extranodal origin. The authors discuss the use of various topical agents, including corticosteroids, chemotherapeutic drugs, bexarotene gel, electron beam therapy, and phototherapy. The review also highlights promising new and experimental therapies, such as tazarotene, imiquimod, gene therapy, rituximab, photodynamic therapy, and 308-nm excimer laser. These therapies offer potential for improved treatment outcomes and reduced side effects for patients with CLs.

Breaking New Ground in Cutaneous Lymphoma Treatment

This review provides a comprehensive overview of the latest advances in skin-directed therapies for cutaneous lymphomas. The authors discuss the importance of targeted treatment approaches for different subtypes of CLs. The review also highlights the emergence of new and experimental therapies that offer hope for improved treatment outcomes and reduced side effects.

Navigating Cutaneous Lymphoma: A Personalized Approach

This research underscores the importance of a personalized approach to cutaneous lymphoma treatment. The choice of therapy should be tailored to the specific subtype of lymphoma, stage of disease, and individual patient characteristics. The review highlights the importance of continued research and development in this area to provide patients with the most effective and safe treatment options.

Dr. Camel's Conclusion

Just as a camel navigates the desert, seeking out the most suitable paths, this research navigates the complex landscape of cutaneous lymphoma treatment. The review highlights the importance of targeted therapies and the exciting potential of new and experimental approaches. It's a testament to the ongoing progress in the field of cancer research and offers hope for improved treatment outcomes and better quality of life for patients with CLs.

Date :
  1. Date Completed 2010-01-25
  2. Date Revised 2012-11-15
Further Info :

Pubmed ID

19786826

DOI: Digital Object Identifier

10.1159/000241302

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.